Interfering with antiviral pathway may deter Alzheimer's disease and frontotemporal dementia

Targeting part of an antiviral pathway triggered by the accumulation of a key pathogen shared in Alzheimer's disease and frontotemporal dementia may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

from Breaking World Pharma News https://ift.tt/dNaxDwc